Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Population pharmacokinetics/pharmacodynamics modeling: parametric and nonparametric methods.

R Jelliffe1, A Schumitzky, M Van Guilder

  • 1Laboratory of Applied Pharmacokinetics, USC School of Medicine, Los Angeles, USA.

Therapeutic Drug Monitoring
|June 13, 2000
PubMed
Summary

Population pharmacokinetic modeling captures clinical drug experience in patient groups. This approach links drug behavior to clinical effects and pharmacodynamic models for better understanding.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance.

Antimicrobial agents and chemotherapy·2015
Same author

Population modeling and simulation study of the pharmacokinetics and antituberculosis pharmacodynamics of isoniazid in lungs.

Antimicrobial agents and chemotherapy·2015
Same author

Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy.

Antimicrobial agents and chemotherapy·2014
Same author

Individual dose optimization: why and how.

International journal of clinical pharmacology and therapeutics·2004
Same author

Renal elimination of amikacin and the aging process.

Clinical pharmacokinetics·2001
Same author

Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.

Antimicrobial agents and chemotherapy·2001

Area of Science:

  • Pharmacokinetics
  • Pharmacodynamics
  • Clinical Pharmacology

Background:

  • Clinicians gain experience with drug behavior over time.
  • This experience is often anecdotal and not systematically recorded.
  • Understanding drug behavior in specific patient populations is crucial.

Purpose of the Study:

  • To describe the optimal method for recording clinical experience with drug behavior.
  • To introduce population pharmacokinetic modeling as a tool for this purpose.
  • To explain how these models link drug behavior to clinical outcomes.

Main Methods:

  • Developing population pharmacokinetic models.
  • Integrating clinical and pharmacokinetic data.
  • Linking pharmacokinetic models to pharmacodynamic models or clinical effects.

Related Experiment Videos

Main Results:

  • Population models provide a structured way to record clinical experience.
  • These models describe drug behavior within a defined patient population.
  • The models facilitate the relationship between drug exposure and response.

Conclusions:

  • Population pharmacokinetic modeling is essential for documenting clinical drug experience.
  • It enhances the understanding of drug behavior in specific patient groups.
  • This approach supports evidence-based clinical decision-making.